Takeda new business venture with Teva
Takeda Pharmaceutical Company Limited, a research-based global company, and Teva Pharmaceutical Industries Ltd, a leading global pharmaceutical company, have announced the follow... Read More
Biocon launched Gilead Sciences’ Hepatitis C drug – CIMIVIR-L in India
BIopharmaceutical company Biocon on Thursday said it has launched a generic version of Gilead Sciences’ Hepatitis C drug, Harvoni, in India. The... Read More
Recipharm’s manufacturing pact with Alcon & acquires facility in France
Posted on25 Dec 2015
Comments0
Recipharm AB, a leading contract development and manufacturing organisation in the pharmaceutical industry, has entered into the previously announced strategic collaboration with... Read More
Case Study: Revlimid patent litigation settlement in US
About Revlimid: In the US, Revlimid (lenalidomide) in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma. Revlimid... Read More
Strategic Deal : Amgen Regain Rights of Prolia, Xgeva & Vectibix brands from Glaxo
About the deal: Amgen has entered into a definitive agreement with GlaxoSmithKline plc. Under this agreement, Amgen will regain all remaining rights... Read More
Lilly and Merck’s Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA Combination Trial
Eli Lilly and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib... Read More
Sanofi received 1st regulatory approval for dengue vaccine, DENGVAXIA®
Sanofi Pasteur, the vaccines division of Sanofi, announced that the Mexican authorities have granted marketing authorization to Dengvaxia®, making it the first... Read More
Case Study: Packaging Innovation as a part of product differentiating strategy in pharmaceuticals
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) is introducing new generic drugs under generics subsidiary, Daiichi Sankyo Espha, Product name Therapeutic category... Read More